NHC
CLOV icon

Nicholas Hoffman & Company’s Clover Health Investments CLOV Stock Holding History

Nicholas Hoffman & Company’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,000
Closed -$36K – 265
2022
Q1 		$36K Buy
+10,000
New +$29K ﹤0.01% 274

Other funds holding CLOV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Nicholas Hoffman & Company's CLOV Position: Q2 2022 in Review

Nicholas Hoffman & Company sold out of Clover Health Investments (CLOV) in Q2 2022, closing a stake of 10,000 shares — an estimated $36K sold.

Nicholas Hoffman & Company first reported a position in CLOV in Q1 2022 and held it in 1 quarter. The position peaked at $36K in Q1 2022. 176 funds tracked by Wall St. Rank hold CLOV as of Q2 2022.

  • Nicholas Hoffman & Company reported no remaining Clover Health Investments position as of Q2 2022 after selling out during the quarter.
  • Nicholas Hoffman & Company sold 10,000 Clover Health Investments shares in Q2 2022, an estimated $36K.
  • Nicholas Hoffman & Company first reported a position in Clover Health Investments in Q1 2022 and held it in 1 quarter.
  • Nicholas Hoffman & Company's Clover Health Investments position peaked at $36K in Q1 2022.
  • 176 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2022.

Based on Nicholas Hoffman & Company's 13F filing for Q2 2022, filed 9 Aug 2022.